Investment
Features
FeesSafety
Academy
More
Pluang+

Skydance CEO vows CNN's editorial independence amid Paramount-Warner merger and potential layoffs.

Market News
06 Oct 2026
New York Post
View Source
Neutral
Skydance CEO vows CNN's editorial independence amid Paramount-Warner merger and potential layoffs.

Following the $81 billion Paramount-Warner Bros. Discovery merger, Skydance CEO David Ellison assured CNN staff and viewers that CNN will maintain complete editorial independence under the new media giant. In a town hall interview with Anderson Cooper, Ellison emphasized the importance of fact-based journalism and pledged not to interfere with news coverage, including CNN's ongoing lawsuit to restore White House access. The merger combines major studios, streaming services, and news outlets, but also raises concerns about layoffs and industry job losses. Ellison and co-CEO Ynon Kreiz acknowledged potential workforce changes but committed to handling them thoughtfully while focusing on digital growth and expanding production.

David Ellison's reassurance about CNN's independence comes amid a media sector snapshot from Pluang. As of Oct 07, 2026 04:13 WIB, 31 of 45 media-sector US stocks rose while 14 fell. Notable movers include Weibo Corp at USD 6.48 with a 2.37% gain and Bumble Inc at USD 2.57 with a 2.28% loss in one day.

More News

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...

Company Fundamentals
Bullish
1 hour ago
Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...

Company Fundamentals
Neutral
1 hour ago
Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...

Market News
Bullish
1 hour ago
Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...

Market News
Bearish
1 hour ago
Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App